By Missy Zolecki

Many individuals with Fragile X syndrome (FXS) exhibit delays in development and can also have challenging behaviors, both of which can impact academic and daily functioning. Medications are at times helpful to facilitate the individual’s ability to attain optimal life skills and allow for better integration into educational, adult, and social environments.

There are several common symptoms and psychiatric conditions in individuals with Fragile X syndrome that are treated with the same medications used in the general population and in individuals with other developmental disabilities. These medications have been reported to be effective for individuals with Fragile X syndrome in retrospective clinical studies. However, it’s important to note that there is limited formal research or clinical trial data to demonstrate the best approach to the use of medication specifically in the Fragile X syndrome population.

Dr. Craig Erickson, Medical Director at the Fragile X Clinic at Cincinnati Children’s Hospital Medical Center, joins us for our 10th annual webinar focused on Medication for Individuals with Fragile X Syndrome.

Guided by moderator Jayne Dixon Weber, Dr. Erickson shares the latest updates on medications and research followed by a Q&A session. He provides a wealth of information for a variety of ages, behaviors, and medications.

The latest treatment recommendation on Medications for Individuals with Fragile X Syndrome is available to read and/or download and is a resource that provides additional information on many of the medications discussed during the webinar.

Note and Disclaimer: The National Fragile X Foundation (NFXF) does not provide medical or legal advice or services. Rather, the NFXF provides general information about Fragile X as a service to the community. The information provided in this document is not an endorsement of any resource, therapeutic method, or service provider and does not replace the advice of medical, legal, or educational professionals. The NFXF has not validated and is not responsible for any information or services provided by third parties. Use independent judgment, request references, and seek the advice of or consult your physician when considering any information or treatment related to Fragile X.


Medications for Individuals with Fragile X Syndrome
From our treatment recommendations written by members of the Fragile X Clinic & Research Consortium committee, and written for professionals working with Fragile X syndrome patients, and made available as a resource to families and parents.

Missy Zolecki, Director, Community Empowerment

Missy Zolecki
Missy joined NFXF team in 2018 after being an active volunteer since 2010. Missy organized several fundraisers and educational workshops while serving in her volunteer role. Missy is the mother of three children. Her eldest son, Matt, lives with Fragile X syndrome. Prior to joining the NFXF team, Missy had worked as a nurse for more than 20 years. She enjoys traveling and spending time with family and friends.